Literature DB >> 29928775

Perfusion settings and additives in liver normothermic machine perfusion with red blood cells as oxygen carrier. A systematic review of human and porcine perfusion protocols.

Dilmurodjon Eshmuminov1, Filippo Leoni1, Marcel André Schneider1, Dustin Becker2, Xavier Muller1, Christopher Onder3, Max Hefti2, Martin J Schuler2, Philipp Dutkowski1, Rolf Graf1, Philipp Rudolf von Rohr4, Pierre-Alain Clavien1, Lucia Bautista Borrego1.   

Abstract

Liver machine perfusion (MP) at normothermic temperature (NMP) is a promising way to preserve and evaluate extended criteria donor livers. Currently, no consensus exists in methodology and perfusion protocols. Here, the authors performed a systematic literature search to identify human and porcine studies reporting on liver NMP with red blood cells. A qualitative synthesis was performed concerning technical aspects of MP, fluid composition, gas supply, and liver positioning. Thirty-seven publications including 11 human and 26 porcine studies were considered for qualitative synthesis. Control mode, pressure, flow, perfusate additives, and targeted blood gas parameters varied across human as well as porcine studies. For future analyses, it is advisable to report flow adjusted to liver weight and exact pressure parameters including mean, systolic, and diastolic pressure. Parenteral nutrition and insulin addition was common. Parenteral nutrition included amino acids and/or glucose without lipids. Taurocholic acid derivatives were used as bile flow promoters. However, short-term human NMP without taurocholic acid derivatives seems to be possible. This finding is relevant due to the lack of clinical grade bile salts. Near physiological oxygen tension in the perfusate is doable by adjusting gas flows, while blood gas parameters regulation needs more detailed description.
© 2018 Steunstichting ESOT.

Entities:  

Keywords:  liver normothermic machine perfusion

Year:  2018        PMID: 29928775     DOI: 10.1111/tri.13306

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

1.  The Immunological Effect of Oxygen Carriers on Normothermic Ex Vivo Liver Perfusion.

Authors:  Heather Jennings; Kristin N Carlson; Chris Little; Joshua C Verhagen; Jeevan Nagendran; Yongjun Liu; Bret Verhoven; Weifeng Zeng; Stacey McMorrow; Peter Chlebeck; David P Al-Adra
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

Review 2.  Restoring Mitochondrial Function While Avoiding Redox Stress: The Key to Preventing Ischemia/Reperfusion Injury in Machine Perfused Liver Grafts?

Authors:  Julia Hofmann; Giorgi Otarashvili; Andras Meszaros; Susanne Ebner; Annemarie Weissenbacher; Benno Cardini; Rupert Oberhuber; Thomas Resch; Dietmar Öfner; Stefan Schneeberger; Jakob Troppmair; Theresa Hautz
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

3.  Hyperoxia in portal vein causes enhanced vasoconstriction in arterial vascular bed.

Authors:  Dilmurodjon Eshmuminov; Dustin Becker; Max L Hefti; Matteo Mueller; Catherine Hagedorn; Philipp Dutkowski; Philipp Rudolf von Rohr; Maximilian Halbe; Stephan Segerer; Mark W Tibbitt; Lucia Bautista Borrego; Martin J Schuler; Pierre-Alain Clavien
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379

4.  The use of ex-vivo liver perfusion circuit in sheep model: Preliminary report.

Authors:  Mohammed I Al-Sebayel; Yasser M El-Sheikh; Falah H Al-Mohanna; Saleh I Al Abbad; Yaser H Al Nemry; Ahmed Al-Jammali; Norah K Al-Zeer; Yazeed M Alsebayel; Hamad M Al-Bahli
Journal:  Saudi Med J       Date:  2021-12       Impact factor: 1.422

5.  Normothermic Ex Vivo Liver Platform Using Porcine Slaughterhouse Livers for Disease Modeling.

Authors:  Melanie Krüger; Alicia Ruppelt; Benjamin Kappler; Elke Van Soest; Roos Anne Samsom; Guy C M Grinwis; Niels Geijsen; J Bernd Helms; Marco Stijnen; Linda M Kock; Marco Rasponi; Hans S Kooistra; Bart Spee
Journal:  Bioengineering (Basel)       Date:  2022-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.